Glow Lifetech Corp. (GLWLF)
- Previous Close
0.0000 - Open
0.0400 - Bid 0.0400 x --
- Ask 0.0439 x --
- Day's Range
0.0400 - 0.0400 - 52 Week Range
0.0203 - 0.0825 - Volume
4,000 - Avg. Volume
14,511 - Market Cap (intraday)
6.915M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products. The company exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K and iron. It engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company provides its products under MOD and .decimal brands. Glow Lifetech Corp. was founded in 1988 and is headquartered in Toronto, Canada.
glowlifetech.comRecent News: GLWLF
View MorePerformance Overview: GLWLF
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GLWLF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GLWLF
View MoreValuation Measures
Market Cap
5.98M
Enterprise Value
5.59M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.24
Price/Book (mrq)
13.07
Enterprise Value/Revenue
14.04
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-34.01%
Return on Equity (ttm)
-248.66%
Revenue (ttm)
836.19k
Net Income Avi to Common (ttm)
-2.66M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
1.29M
Total Debt/Equity (mrq)
15.72%
Levered Free Cash Flow (ttm)
-1.67M